Literature DB >> 23575663

Modifiable risk behaviors in patients with head and neck cancer.

Janani Sivasithamparam1, Carly A Visk, Ezra E W Cohen, Andrea C King.   

Abstract

BACKGROUND: Use of tobacco products, excessive alcohol consumption, and high-risk sexual behaviors increase the risk of developing head and neck cancer and impacts treatment effectiveness after diagnosis. This study examined smoking and engagement in other modifiable behavioral risk factors and human papillomavirus (HPV) status in patients with head and neck cancer in order to facilitate identification and foster development of targeted interventions in high-risk patients.
METHODS: Participants were 102 patients with head and neck cancer at a large urban cancer center who completed a self-report background and health questionnaire and provided a saliva sample for determination of the long-acting nicotine metabolite cotinine.
RESULTS: Compared with former and never-smokers, current smokers were less educated, less likely to be married or living with a partner, and consumed more alcohol. Cotinine analysis indicated that 4 of 16 (25%) patients who denied past-month cigarette use misrepresented their true smoking status. Of patients with oropharyngeal cancer, 74% were confirmed as HPV-positive, and compared with HPV-negative patients, they were younger, more likely to be married/partnered and of Caucasian race, and reported more past vaginal and oral sexual partners. Only one-third of HPV-positive patients were aware of their HPV disease status.
CONCLUSIONS: Cigarette smoking is associated with engagement in other modifiable risk factors in patients with head and neck cancer. Self-report measures of smoking may not accurately depict true smoking status. HPV-positive cancer patients were more likely to endorse a history of multiple sexual partners. Regular screening and targeted interventions for these distinct risk factors are warranted.
Copyright © 2013 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575663      PMCID: PMC3687000          DOI: 10.1002/cncr.27993

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

Review 2.  Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Authors:  Jan Klozar; Ruth Tachezy; Eliška Rotnáglová; Eva Košlabová; Martina Saláková; Eva Hamšíková
Journal:  Wien Med Wochenschr       Date:  2010-06

3.  Smoking and drinking in relation to oral and pharyngeal cancer.

Authors:  W J Blot; J K McLaughlin; D M Winn; D F Austin; R S Greenberg; S Preston-Martin; L Bernstein; J B Schoenberg; A Stemhagen; J F Fraumeni
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

Review 4.  A review of the use of saliva cotinine as a marker of tobacco smoke exposure.

Authors:  R A Etzel
Journal:  Prev Med       Date:  1990-03       Impact factor: 4.018

5.  Stages of change, smoking characteristics, and cotinine concentrations in smokers: setting priorities for smoking cessation.

Authors:  Marcela Fu; Esteve Fernández; José A Pascual; Jose M Martínez-Sánchez; Antoni Agudo; Albert Moncada; Manel Nebot; Josep M Borràs
Journal:  Prev Med       Date:  2010-12-14       Impact factor: 4.018

6.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.

Authors:  Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Cancer Causes Control       Date:  2010-04-17       Impact factor: 2.506

7.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

Review 8.  Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.

Authors:  Christine H Chung; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

9.  Continued alcohol use in patients with head and neck cancer.

Authors:  Andrea E Potash; Lucy Hynds Karnell; Alan J Christensen; Mark W Vander Weg; Gerry F Funk
Journal:  Head Neck       Date:  2010-07       Impact factor: 3.147

10.  Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy.

Authors:  Jonas Hald; Jens Overgaard; Cai Grau
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

View more
  12 in total

1.  Smoking status and symptom burden in surgical head and neck cancer patients.

Authors:  Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver
Journal:  Laryngoscope       Date:  2016-07-09       Impact factor: 3.325

2.  Dietary counselling and nutritional support in oropharyngeal cancer patients treated with radiotherapy: persistent weight loss during 1-year follow-ups.

Authors:  C P Vlooswijk; P H E van Rooij; J C Kruize; H A Schuring; A Al-Mamgani; N M de Roos
Journal:  Eur J Clin Nutr       Date:  2015-07-22       Impact factor: 4.016

3.  Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey.

Authors:  Ulrike Schiller; Johanna Inhestern; Ulrike Burger; Susanne Singer; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-13       Impact factor: 2.503

4.  Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.

Authors:  Prokopios P Argyris; Zachary Slama; Chris Malz; Ioannis G Koutlas; Betty Pakzad; Ketan Patel; Deepak Kademani; Ali Khammanivong; Mark C Herzberg
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

5.  The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients.

Authors:  Katherine R Sterba; Kathryn E Weaver; Anthony J Alberg; Mitchell L Worley; Janet A Tooze; Jeanne L Hatcher; Matthew J Carpenter; Terry A Day; Christopher A Sullivan; Graham W Warren
Journal:  Otolaryngol Head Neck Surg       Date:  2015-07-20       Impact factor: 3.497

Review 6.  The role of sexual behavior in head and neck cancer: implications for prevention and therapy.

Authors:  Eleni Rettig; Ana Ponce Kiess; Carole Fakhry
Journal:  Expert Rev Anticancer Ther       Date:  2014-09-05       Impact factor: 4.512

7.  High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.

Authors:  E Lukesova; J Boucek; E Rotnaglova; M Salakova; E Koslabova; M Grega; T Eckschlager; B Rihova; B Prochazka; J Klozar; R Tachezy
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

8.  Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.

Authors:  Chung-Guei Huang; Li-Ang Lee; Chun-Ta Liao; Tzu-Chen Yen; Shu-Li Yang; Yi-Chun Liu; Jung-Chin Li; Yu-Nong Gong; Chung-Jan Kang; Shiang-Fu Huang; Ku-Hao Fang; Kai-Ping Chang; Li-Yu Lee; Chuen Hsueh; Shin-Ru Shih; Kuo-Chien Tsao
Journal:  Oncotarget       Date:  2017-05-23

Review 9.  Oral sex and oropharyngeal cancer: The role of the primary care physicians.

Authors:  Nam P Nguyen; Ly M Nguyen; Sroka Thomas; Bevan Hong-Ly; Alexander Chi; Paul Vos; Ulf Karlsson; Vincent Vinh-Hung
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 10.  Smoking cessation care among patients with head and neck cancer: a systematic review.

Authors:  Kristen McCarter; Úrsula Martínez; Ben Britton; Amanda Baker; Billie Bonevski; Gregory Carter; Alison Beck; Chris Wratten; Ashleigh Guillaumier; Sean A Halpin; Luke Wolfenden
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.